Benzinga | May 10, 2021 07:09AM EDT

TG Therapeutics Q1 EPS $(0.69) Misses $(0.49) Estimate, Sales $793.00K Beat $650.00K Estimate

TG Therapeutics (NASDAQ:TGTX) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.49) by 40.82 percent. This is a 43.75 percent decrease over losses of $(0.48) per share from the same period last year. The company reported quarterly sales of $793.00 thousand which beat the analyst consensus estimate of $650.00 thousand by 22.00 percent. This is a 1.99K percent increase over sales of $38.00 thousand the same period last year.